03:16 AM EDT, 09/16/2025 (MT Newswires) -- Stephen Michael Kelsey, President, Research and Development, on September 11, 2025, sold 125,000 shares in Revolution Medicines ( RVMD ) for $5,557,754. Following the Form 4 filing with the SEC, Kelsey has control over a total of 289,414 common shares of the company, with 289,414 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1628171/000161071725000339/xslF345X05/form4.xml